Medicine guide
Indimacis 125
·
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Igovomab
- Made by
- CIS bio international
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Positive diagnosis of relapsing ovarian adenocarcinoma when serum CA 125 is increased without positive results of ultrasound or computerised tomography scan.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | CIS bio international |
|---|---|
| Active substance | Igovomab |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V09IB03 · Everything that fits nowhere else, such as contrast media |
| Authorised on | 1996-10-04 |
| Last updated by the regulator | 2009-12-31 |
| EMA product number | EMEA/H/C/000065 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).